Logo image of VYX

NCR VOYIX CORP (VYX) Stock Fundamental Analysis

NYSE:VYX - New York Stock Exchange, Inc. - US62886E1082 - Common Stock - Currency: USD

8.75  +0.09 (+1.04%)

After market: 8.75 0 (0%)

Fundamental Rating

3

VYX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 283 industry peers in the Software industry. VYX has a medium profitability rating, but doesn't score so well on its financial health evaluation. VYX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year VYX was profitable.
In the past year VYX has reported a negative cash flow from operations.
In multiple years VYX reported negative net income over the last 5 years.
VYX had a positive operating cash flow in 4 of the past 5 years.
VYX Yearly Net Income VS EBIT VS OCF VS FCFVYX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

VYX has a Return On Assets of 20.19%. This is amongst the best in the industry. VYX outperforms 95.05% of its industry peers.
The Return On Equity of VYX (74.36%) is better than 97.17% of its industry peers.
VYX's Return On Invested Capital of 1.77% is fine compared to the rest of the industry. VYX outperforms 69.26% of its industry peers.
Industry RankSector Rank
ROA 20.19%
ROE 74.36%
ROIC 1.77%
ROA(3y)4.26%
ROA(5y)2.43%
ROE(3y)-21.78%
ROE(5y)-13.67%
ROIC(3y)N/A
ROIC(5y)N/A
VYX Yearly ROA, ROE, ROICVYX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

The Profit Margin of VYX (24.38%) is better than 90.81% of its industry peers.
VYX's Profit Margin has improved in the last couple of years.
The Operating Margin of VYX (1.84%) is better than 67.14% of its industry peers.
VYX's Operating Margin has declined in the last couple of years.
VYX's Gross Margin of 21.01% is on the low side compared to the rest of the industry. VYX is outperformed by 81.63% of its industry peers.
In the last couple of years the Gross Margin of VYX has declined.
Industry RankSector Rank
OM 1.84%
PM (TTM) 24.38%
GM 21.01%
OM growth 3Y-43.61%
OM growth 5Y-31.2%
PM growth 3Y208.92%
PM growth 5Y38.43%
GM growth 3Y-8.16%
GM growth 5Y-5.91%
VYX Yearly Profit, Operating, Gross MarginsVYX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VYX is destroying value.
VYX has less shares outstanding than it did 1 year ago.
VYX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for VYX has been reduced compared to a year ago.
VYX Yearly Shares OutstandingVYX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
VYX Yearly Total Debt VS Total AssetsVYX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 1.34, we must say that VYX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.34, VYX perfoms like the industry average, outperforming 44.17% of the companies in the same industry.
A Debt/Equity ratio of 0.91 indicates that VYX is somewhat dependend on debt financing.
VYX has a worse Debt to Equity ratio (0.91) than 72.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Altman-Z 1.34
ROIC/WACC0.18
WACC10.02%
VYX Yearly LT Debt VS Equity VS FCFVYX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

VYX has a Current Ratio of 1.18. This is a normal value and indicates that VYX is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.18, VYX is not doing good in the industry: 66.78% of the companies in the same industry are doing better.
A Quick Ratio of 1.03 indicates that VYX should not have too much problems paying its short term obligations.
VYX's Quick ratio of 1.03 is on the low side compared to the rest of the industry. VYX is outperformed by 73.14% of its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.03
VYX Yearly Current Assets VS Current LiabilitesVYX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

3

3. Growth

3.1 Past

The earnings per share for VYX have decreased strongly by -73.01% in the last year.
The earnings per share for VYX have been decreasing by -31.03% on average. This is quite bad
Looking at the last year, VYX shows a very negative growth in Revenue. The Revenue has decreased by -62.07% in the last year.
VYX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -16.39% yearly.
EPS 1Y (TTM)-73.01%
EPS 3Y-44.54%
EPS 5Y-31.03%
EPS Q2Q%126.83%
Revenue 1Y (TTM)-62.07%
Revenue growth 3Y-26.63%
Revenue growth 5Y-16.39%
Sales Q2Q%-29.18%

3.2 Future

Based on estimates for the next years, VYX will show a very strong growth in Earnings Per Share. The EPS will grow by 20.91% on average per year.
VYX is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -9.06% yearly.
EPS Next Y64.12%
EPS Next 2Y44.63%
EPS Next 3Y20.91%
EPS Next 5YN/A
Revenue Next Year-9.63%
Revenue Next 2Y-12.15%
Revenue Next 3Y-9.06%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
VYX Yearly Revenue VS EstimatesVYX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
VYX Yearly EPS VS EstimatesVYX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 19.89 indicates a rather expensive valuation of VYX.
VYX's Price/Earnings ratio is a bit cheaper when compared to the industry. VYX is cheaper than 78.09% of the companies in the same industry.
When comparing the Price/Earnings ratio of VYX to the average of the S&P500 Index (23.99), we can say VYX is valued inline with the index average.
VYX is valuated correctly with a Price/Forward Earnings ratio of 12.12.
Based on the Price/Forward Earnings ratio, VYX is valued cheaply inside the industry as 89.75% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.35, VYX is valued a bit cheaper.
Industry RankSector Rank
PE 19.89
Fwd PE 12.12
VYX Price Earnings VS Forward Price EarningsVYX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

97.53% of the companies in the same industry are more expensive than VYX, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.3
VYX Per share dataVYX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as VYX's earnings are expected to grow with 20.91% in the coming years.
PEG (NY)0.31
PEG (5Y)N/A
EPS Next 2Y44.63%
EPS Next 3Y20.91%

0

5. Dividend

5.1 Amount

No dividends for VYX!.
Industry RankSector Rank
Dividend Yield N/A

NCR VOYIX CORP

NYSE:VYX (5/7/2025, 8:04:00 PM)

After market: 8.75 0 (0%)

8.75

+0.09 (+1.04%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-27 2025-02-27/bmo
Earnings (Next)05-08 2025-05-08/bmo
Inst Owners104.9%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner Change7.65%
Market Cap1.21B
Analysts83.08
Price Target14.47 (65.37%)
Short Float %14.85%
Short Ratio9.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP1.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)77.79%
Min EPS beat(2)55.59%
Max EPS beat(2)100%
EPS beat(4)3
Avg EPS beat(4)72.41%
Min EPS beat(4)-45.76%
Max EPS beat(4)179.81%
EPS beat(8)5
Avg EPS beat(8)7.15%
EPS beat(12)7
Avg EPS beat(12)2%
EPS beat(16)10
Avg EPS beat(16)2.64%
Revenue beat(2)1
Avg Revenue beat(2)0.07%
Min Revenue beat(2)-1.67%
Max Revenue beat(2)1.8%
Revenue beat(4)1
Avg Revenue beat(4)-4.91%
Min Revenue beat(4)-19.37%
Max Revenue beat(4)1.8%
Revenue beat(8)3
Avg Revenue beat(8)10.92%
Revenue beat(12)4
Avg Revenue beat(12)6.7%
Revenue beat(16)5
Avg Revenue beat(16)4.53%
PT rev (1m)-10.63%
PT rev (3m)-16.82%
EPS NQ rev (1m)-60.63%
EPS NQ rev (3m)-87.13%
EPS NY rev (1m)-7.31%
EPS NY rev (3m)-21.18%
Revenue NQ rev (1m)1.07%
Revenue NQ rev (3m)13.19%
Revenue NY rev (1m)3.57%
Revenue NY rev (3m)18.47%
Valuation
Industry RankSector Rank
PE 19.89
Fwd PE 12.12
P/S 0.33
P/FCF N/A
P/OCF N/A
P/B 1
P/tB N/A
EV/EBITDA 4.3
EPS(TTM)0.44
EY5.03%
EPS(NY)0.72
Fwd EY8.25%
FCF(TTM)-2.53
FCFYN/A
OCF(TTM)-0.96
OCFYN/A
SpS26.68
BVpS8.75
TBVpS-2.9
PEG (NY)0.31
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 20.19%
ROE 74.36%
ROCE 2.24%
ROIC 1.77%
ROICexc 2.33%
ROICexgc 7.7%
OM 1.84%
PM (TTM) 24.38%
GM 21.01%
FCFM N/A
ROA(3y)4.26%
ROA(5y)2.43%
ROE(3y)-21.78%
ROE(5y)-13.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-36.27%
ROICexcg growth 5Y-25.75%
ROICexc growth 3Y-36.4%
ROICexc growth 5Y-30.51%
OM growth 3Y-43.61%
OM growth 5Y-31.2%
PM growth 3Y208.92%
PM growth 5Y38.43%
GM growth 3Y-8.16%
GM growth 5Y-5.91%
F-Score5
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Debt/EBITDA 3.01
Cap/Depr 73.06%
Cap/Sales 5.88%
Interest Coverage 0.47
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 1.03
Altman-Z 1.34
F-Score5
WACC10.02%
ROIC/WACC0.18
Cap/Depr(3y)67.44%
Cap/Depr(5y)68.37%
Cap/Sales(3y)8.12%
Cap/Sales(5y)6.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.01%
EPS 3Y-44.54%
EPS 5Y-31.03%
EPS Q2Q%126.83%
EPS Next Y64.12%
EPS Next 2Y44.63%
EPS Next 3Y20.91%
EPS Next 5YN/A
Revenue 1Y (TTM)-62.07%
Revenue growth 3Y-26.63%
Revenue growth 5Y-16.39%
Sales Q2Q%-29.18%
Revenue Next Year-9.63%
Revenue Next 2Y-12.15%
Revenue Next 3Y-9.06%
Revenue Next 5YN/A
EBIT growth 1Y-91.25%
EBIT growth 3Y-58.63%
EBIT growth 5Y-42.48%
EBIT Next Year380.19%
EBIT Next 3Y71.59%
EBIT Next 5YN/A
FCF growth 1Y-210.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-119.02%
OCF growth 3YN/A
OCF growth 5YN/A